07/25/2019
LATEST UPDATE ON BREAST IMPLANTS AND ASSOCIATED CANCER
Today, the FDA has announced that Allergan has been requested and has voluntarily recalled certain textured covered breast implants and expanders. This is based on the latest released information that now suggests that the BIOCELL textured covering on Allergan implants is more likely to cause breast implant associated anaplastic large cell lymphoma (ALCL) than other manufactured implants.
What is ALCL? It is not breast cancer. It is a type of non-Hodgkin's lymphoma.
So what is the data? According to the FDA, since ALCL was first reported about 10 years ago, there have been a total of 573 cases reported worldwide of breast implant associated ALCL (BIA-ALCL). It typically develops many years after the implants have been inserted. When discovered, typically it responds well to treatment. There have been a total of 33 deaths. 12 of those deaths have been associated with Allergan implants. In 20 of the deaths, the type of implant is unknown. One should keep in mind that last year alone over 300,000 women had implants inserted in the United States.
The American Society of Plastic Surgeons (ASPS) and the FDA have been monitoring the situation with ALCL for close to 10 years. Both organizations are doing their best to provide the latest information and keep women aware of the latest developments. Information about ALCL has been a part of the ASPS consent form that is used in my office since 2012.
So what should women with breast implants, especially textured implants or expanders do now? First of all, the FDA continues to state the they are not recommending removal of these or other types of implants due to the low risk of developing ALCL.
What are the symptoms of ALCL? Persistent swelling due to fluid or pain, or palpable mass are the mentioned symptoms. Typically, patients who having symptoms such as this are encouraged to see their health care provider to rule out issues related to their breast implants and/or their past history of breast cancer. In most cases, seeing the plastic surgeon that inserted your implants would be an appropriate first step. In some cases further evaluation with your other health care providers such as your breast surgeon or oncologist may be recommended.
I would like to mention that it is not uncommon for women with breast implants to have some occasional breast discomfort and most typically it is due to scar tissue such as scar contracture around the implant. To put this all into perspective, as I mentioned in a post back in February, in over 28 years of private practice, I have never seen a case of ALCL and none of the oncologists that I work with have seen a case of breast implant associated ALCL. However, the FDA, the ASPS and I want to continue to make sure our patients are well informed about the products and medical devices that are being used and most importantly that their safety and well-being remain our number one priority.
If you have any further questions or concerns regarding your implants, please contact our office.